Copyright 2022 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.26 USD | +1.00% | +1.35% | -8.79% |
Apr. 22 | Pfizer: new Emblaveo antibiotic approved in the EU | CF |
Apr. 22 | Pfizer's Emblaveo Receives European Commission Marketing Approval | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.79% | 149B | |
+25.46% | 659B | |
+25.34% | 557B | |
-4.86% | 359B | |
+16.44% | 322B | |
+8.34% | 297B | |
+6.55% | 215B | |
+7.79% | 210B | |
-6.75% | 200B | |
-5.59% | 146B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Pfizer says three COVID-19 vaccine doses protect kids under 5, company plans to give data to U.S. regulators this week